VCTC

VCTC, founded in 2022 and headquartered in the United Kingdom, stands out in the Biotechnology and Health Care industries with its mission to make clinical trials more accessible ("Making clinical trials more accessible. A specialist clinical trial centre delivering virtual and decentralised trials"). The company is pioneering a novel approach to clinical research, focusing on virtual and decentralized trials, which has shown to improve recruitment speed and diversity, ultimately enhancing research outcomes and accelerating the introduction of medical treatments.

Backed by a team of medical and scientific specialists, VCTC not only supports the full spectrum of clinical research but also places strong emphasis on participant-centered experiences—boasting exceptional retention rates and enriched evidence quality. The company recently secured an acquisition investment from Medical Research Network on 01 January 2025, indicating strong investor confidence in its innovative model and growth potential in transforming global clinical research practices.